Johnson & Johnson Just Got FDA Clearance for Its Surgical Robot, Hiked Its Dividend for the 64th Time, and Is Targeting $100 Billion in Revenue. But Here’s What Investors Should Be Most Excited About
Johnson & Johnson (JNJ -3.66%) is having a great year. The healthcare giant’s shares are up 28% compared…
